Ascentage Pharma's Series C Round

Ascentage Pharma raised a round of funding on July 17, 2018.

Ascentage Pharma (亚盛医药) is a globally-focused clinical-stage biopharmaceutical company developing targeted therapeutics for cancers, hepatitis B & age-related diseases.…

Articles about Ascentage Pharma's Series C Round: